BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31719297)

  • 1. Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia.
    de Oliveira FF; Berretta JM; de Almeida Junior GV; de Almeida SS; Chen ES; Smith MC; Bertolucci PHF
    Indian J Med Res; 2019 Sep; 150(3):261-271. PubMed ID: 31719297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease.
    Ferreira de Oliveira F; Berretta JM; Suchi Chen E; Cardoso Smith M; Ferreira Bertolucci PH
    Colomb Med (Cali); 2016 Jun; 47(2):76-80. PubMed ID: 27546928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia.
    de Oliveira FF; Chen ES; Smith MC; Bertolucci PHF
    Curr Alzheimer Res; 2018 Feb; 15(4):386-398. PubMed ID: 29034839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selected LDLR and APOE Polymorphisms Affect Cognitive and Functional Response to Lipophilic Statins in Alzheimer's Disease.
    de Oliveira FF; Chen ES; Smith MC; Bertolucci PHF
    J Mol Neurosci; 2020 Oct; 70(10):1574-1588. PubMed ID: 32474901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of cerebrovascular metabolism genotypes with neuropsychiatric symptoms and age at onset of Alzheimer's disease dementia.
    Oliveira FF; Chen ES; Smith MC; Bertolucci PH
    Braz J Psychiatry; 2017; 39(2):95-103. PubMed ID: 28099631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic Analyses of Therapeutic Effects of Lipophilic Statins on Cognitive and Functional Changes in Alzheimer's Disease.
    de Oliveira FF; Bertolucci PHF; Chen ES; Smith MC
    J Alzheimers Dis; 2022; 87(1):359-372. PubMed ID: 35311709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of angiotensin modulators according to
    Oliveira FF; Almeida SS; Chen ES; Smith MC; Bertolucci PHF
    Acta Neuropsychiatr; 2023 Dec; 35(6):346-361. PubMed ID: 37605989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-penetrating angiotensin-converting enzyme inhibitors and cognitive change in patients with dementia due to Alzheimer's disease.
    de Oliveira FF; Bertolucci PH; Chen ES; Smith MC
    J Alzheimers Dis; 2014; 42 Suppl 3():S321-4. PubMed ID: 24577465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension.
    Pontremoli R; Ravera M; Viazzi F; Nicolella C; Berruti V; Leoncini G; Giacopelli F; Bezante GP; Sacchi G; Ravazzolo R; Deferrari G
    Kidney Int; 2000 Feb; 57(2):561-9. PubMed ID: 10652033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between ACE and AGT polymorphism and cardiovascular risk in acromegalic patients.
    Erbas T; Cinar N; Dagdelen S; Gedik A; Yorgun H; Canpolat U; Kabakci G; Alikasifoglu M
    Pituitary; 2017 Oct; 20(5):569-577. PubMed ID: 28712073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation-optimized treatment benefit of angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: a 12-year follow-up study.
    Lee JK; Wu CK; Tsai CT; Lin LY; Lin JW; Chien KL; Hwang JJ; Lin CL; Tseng CD; Chiang FT
    Pharmacogenet Genomics; 2013 Apr; 23(4):181-9. PubMed ID: 23407050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.
    Zivko M; Kusec R; Galesić K
    Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals.
    Brugts JJ; Isaacs A; de Maat MP; Boersma E; van Duijn CM; Akkerhuis KM; Uitterlinden AG; Witteman JC; Cambien F; Ceconi C; Remme W; Bertrand M; Ninomiya T; Harrap S; Chalmers J; Macmahon S; Fox K; Ferrari R; Simoons ML; Danser AJ
    J Hypertens; 2011 Mar; 29(3):509-19. PubMed ID: 21157371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
    Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
    J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.
    Wong TY; Szeto CC; Chow KM; Chan JC; Li PK
    Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of APOE haplotypes and measures of cardiovascular risk over gender-dependent cognitive and functional changes in one year in Alzheimer's disease.
    de Oliveira FF; Pereira FV; Pivi GAK; Smith MC; Bertolucci PHF
    Int J Neurosci; 2018 May; 128(5):472-476. PubMed ID: 29064737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-center study of ACE and the risk of late-onset Alzheimer's disease.
    Belbin O; Brown K; Shi H; Medway C; Abraham R; Passmore P; Mann D; Smith AD; Holmes C; McGuinness B; Craig D; Warden D; Heun R; Kölsch H; Love S; Kalsheker N; Williams J; Owen MJ; Carrasquillo M; Younkin S; Morgan K; Kehoe PG
    J Alzheimers Dis; 2011; 24(3):587-97. PubMed ID: 21297258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
    Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
    Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition.
    Hingorani AD; Jia H; Stevens PA; Hopper R; Dickerson JE; Brown MJ
    J Hypertens; 1995 Dec; 13(12 Pt 2):1602-9. PubMed ID: 8903618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.